Calliditas Therapeutics AB (CHIX:CALTXS) Inventories, Finished Goods : kr0 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Calliditas Therapeutics AB Inventories, Finished Goods?

Calliditas Therapeutics AB's quarterly finished goods increased from Sep. 2023 (kr0 Mil) to Dec. 2023 (kr7 Mil) but then declined from Dec. 2023 (kr7 Mil) to Mar. 2024 (kr0 Mil).

Calliditas Therapeutics AB's annual finished goods increased from Dec. 2021 (kr0 Mil) to Dec. 2022 (kr1 Mil) and increased from Dec. 2022 (kr1 Mil) to Dec. 2023 (kr7 Mil).

Calliditas Therapeutics AB Inventories, Finished Goods Historical Data

The historical data trend for Calliditas Therapeutics AB's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Inventories, Finished Goods Chart

Calliditas Therapeutics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.86

6.69

Calliditas Therapeutics AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															-	-	-	6.69	-

Calliditas Therapeutics AB Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Calliditas Therapeutics AB (CHIX:CALTXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calliditas Therapeutics AB (CHIX:CALTXs) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

CALT:USA CALTX:Sweden LC8:Germany LC8A:Germany LC8:Germany

Address

Kungsbron 1, D5, Stockholm, SWE, SE-111 22

Website

https://www.calliditas.se

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.

Calliditas Therapeutics AB (CHIX:CALTXS) Headlines

No Headlines